| ■ 영문 제목 : Global Remimazolam Market Growth 2021-2026 | |
 | ■ 상품코드 : LPI-2201K02162 ■ 조사/발행회사 : LP Information ■ 발행일 : 2021년 12월 (※2025년 최신판이 있습니다. 문의 주세요.) ■ 페이지수 : 91 ■ 작성언어 : 영어 ■ 보고서 형태 : PDF ■ 납품 방식 : E메일 ■ 조사대상 지역 : 글로벌 ■ 산업 분야 : 의약품 |
| Single User (1명 열람용) | USD3,660 ⇒환산￦4,941,000 | 견적의뢰/주문/질문 |
| Multi User (5명 열람용) | USD5,490 ⇒환산￦7,411,500 | 견적의뢰/주문/질문 |
| Corporate User (동일기업내 공유가능) | USD7,320 ⇒환산￦9,882,000 | 견적의뢰/구입/질문 |
|
※가격옵션 설명 - 납기는 즉일~2일소요됩니다. 3일이상 소요되는 경우는 별도표기 또는 연락드립니다. - 지불방법은 계좌이체/무통장입금 또는 카드결제입니다. |
| 본 조사보고서는 레미마졸람의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아, 러시아, 중동/아프리카, 이집트, 남아프리카, 터키, 중동GCC국 등), 시장동향, 판매/유통업자/고객 리스트, 시장예측 (2021년-2026년), 주요 기업동향 (기업정보, 제품, 판매량, 매출, 가격, 매출총이익) 등의 정보를 포함하고 있습니다. 또한, 주요지역의 종류별 시장규모 (2.5mg, 20mg)와 용도별 시장규모 (외과적 마취, ICU 진정, 기타) 데이터도 수록되어 있습니다. - 조사 범위 - 경영자용 요약 - 기업별 레미마졸람 시장 점유율 - 지역별 레미마졸람 시장규모 - 주요지역의 종류별 시장규모 (2.5mg, 20mg) - 주요지역의 용도별 시장규모 (외과적 마취, ICU 진정, 기타) - 미주의 레미마졸람 시장규모 (미국, 캐나다, 멕시코, 브라질 등) - 아시아의 레미마졸람 시장규모 (중국, 일본, 한국, 동남아시아, 인도 등) - 유럽의 레미마졸람 시장규모 (독일, 프랑스, 영국, 이탈리아, 러시아 등) - 중동/아프리카의 레미마졸람 시장규모 (이집트, 남아프리카, 터키, 중동GCC지역 등) - 시장의 성장요인, 과제, 동향 - 마케팅, 유통업자, 고객리스트 - 세계의 레미마졸람 시장예측 (2021년-2026년) - 주요 기업동향 (기업정보, 제품, 판매량, 매출, 가격, 매출총이익) Paion, Yichang Renfu Pharmaceutical, Jiangsu Hengrui Medicine, Cosmo Pharmaceuticals, Mundipharma, Pharmascience, Hana Pharm - 조사의 결과/결론 |
According to this latest study, the 2021 growth of Remimazolam will have significant change from previous year. By the most conservative estimates of global Remimazolam market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the Remimazolam market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026.
This report presents a comprehensive overview, market shares, and growth opportunities of Remimazolam market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.
2.5mg
20mg
Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.
Surgical Anesthesia
ICU Sedation
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.
Paion
Yichang Renfu Pharmaceutical
Jiangsu Hengrui Medicine
Cosmo Pharmaceuticals
Mundipharma
Pharmascience
Hana Pharm
1 Scope of the Report 2 Executive Summary 3 Global Remimazolam by Company 4 Remimazolam by Region 5 Americas 6 APAC 7 Europe 8 Middle East & Africa 9 Market Drivers, Challenges and Trends 10 Marketing, Distributors and Customer 11 Global Remimazolam Market Forecast 12 Key Players Analysis 13 Research Findings and Conclusion List of TablesTable 1. Remimazolam Consumption CAGR by Region (2020-2026) & ($ Millions) Table 2. Major Players of 2.5mg Table 3. Major Players of 20mg Table 4. Global Remimazolam Sales by Type (2016-2021) & (K Units) Table 5. Global Remimazolam Sales Market Share by Type (2016-2021) Table 6. Global Remimazolam Revenue by Type (2016-2021) & ($ million) Table 7. Global Remimazolam Revenue Market Share by Type (2016-2021) Table 8. Global Remimazolam Sale Price by Type (2016-2021) Table 9. Global Remimazolam Sales by Application (2016-2021) & (K Units) Table 10. Global Remimazolam Sales Market Share by Application (2016-2021) Table 11. Global Remimazolam Value by Application (2016-2021) Table 12. Global Remimazolam Revenue Market Share by Application (2016-2021) Table 13. Global Remimazolam Sale Price by Application (2016-2021) Table 14. Global Remimazolam Sales by Company (2019-2021) & (K Units) Table 15. Global Remimazolam Sales Market Share by Company (2019-2021) Table 16. Global Remimazolam Revenue by Company (2019-2021) ($ Millions) Table 17. Global Remimazolam Revenue Market Share by Company (2019-2021) Table 18. Global Remimazolam Sale Price by Company (2019-2021) Table 19. Key Manufacturers Remimazolam Producing Area Distribution and Sales Area Table 20. Players Remimazolam Products Offered Table 21. Remimazolam Concentration Ratio (CR3, CR5 and CR10) & (2019-2021) Table 22. New Products and Potential Entrants Table 23. Mergers & Acquisitions, Expansion Table 24. Global Remimazolam Sales by Region (2016-2021) (K Units) Table 25. Global Remimazolam Sales Market Share by Region (2016-2021) Table 26. Global Remimazolam Revenue by Region (2016-2021) & ($ Millions) Table 27. Global Remimazolam Revenue Market Share by Region (2016-2021) Table 28. Americas Remimazolam Sales by Country (2016-2021) & (K Units) Table 29. Americas Remimazolam Sales Market Share by Country (2016-2021) Table 30. Americas Remimazolam Revenue by Country (2016-2021) & ($ Millions) Table 31. Americas Remimazolam Revenue Market Share by Country (2016-2021) Table 32. Americas Remimazolam Sales by Type (2016-2021) & (K Units) Table 33. Americas Remimazolam Sales Market Share by Type (2016-2021) Table 34. Americas Remimazolam Sales by Application (2016-2021) & (K Units) Table 35. Americas Remimazolam Sales Market Share by Application (2016-2021) Table 36. APAC Remimazolam Sales by Region (2016-2021) & (K Units) Table 37. APAC Remimazolam Sales Market Share by Region (2016-2021) Table 38. APAC Remimazolam Revenue by Region (2016-2021) & ($ Millions) Table 39. APAC Remimazolam Revenue Market Share by Region (2016-2021) Table 40. APAC Remimazolam Sales by Type (2016-2021) & (K Units) Table 41. APAC Remimazolam Sales Market Share by Type (2016-2021) Table 42. APAC Remimazolam Sales by Application (2016-2021) & (K Units) Table 43. APAC Remimazolam Sales Market Share by Application (2016-2021) Table 44. Europe Remimazolam Sales by Country (2016-2021) & (K Units) Table 45. Europe Remimazolam Sales Market Share by Country (2016-2021) Table 46. Europe Remimazolam Revenue by Country (2016-2021) & ($ Millions) Table 47. Europe Remimazolam Revenue Market Share by Country (2016-2021) Table 48. Europe Remimazolam Sales by Type (2016-2021) & (K Units) Table 49. Europe Remimazolam Sales Market Share by Type (2016-2021) Table 50. Europe Remimazolam Sales by Application (2016-2021) & (K Units) Table 51. Europe Remimazolam Sales Market Share by Application (2016-2021) Table 52. Middle East & Africa Remimazolam Sales by Country (2016-2021) & (K Units) Table 53. Middle East & Africa Remimazolam Sales Market Share by Country (2016-2021) Table 54. Middle East & Africa Remimazolam Revenue by Country (2016-2021) & ($ Millions) Table 55. Middle East & Africa Remimazolam Revenue Market Share by Country (2016-2021) Table 56. Middle East & Africa Remimazolam Sales by Type (2016-2021) & (K Units) Table 57. Middle East & Africa Remimazolam Sales Market Share by Type (2016-2021) Table 58. Middle East & Africa Remimazolam Sales by Application (2016-2021) & (K Units) Table 59. Middle East & Africa Remimazolam Sales Market Share by Application (2016-2021) Table 60. Key and Potential Regions of Remimazolam Table 61. Key Application and Potential Industries of Remimazolam Table 62. Key Challenges of Remimazolam Table 63. Key Trends of Remimazolam Table 64. Remimazolam Distributors List Table 65. Remimazolam Customer List Table 66. Global Remimazolam Sales Forecast by Region (2021-2026) & (K Units) Table 67. Global Remimazolam Consumption Market Forecast by Region Table 68. Global Remimazolam Revenue Forecast by Region (2021-2026) & ($ millions) Table 69. Global Remimazolam Revenue Market Share Forecast by Region (2021-2026) Table 70. Americas Remimazolam Sales Forecast by Country (2021-2026) & (K Units) Table 71. Americas Remimazolam Revenue Forecast by Country (2021-2026) & ($ millions) Table 72. APAC Remimazolam Sales Forecast by Region (2021-2026) & (K Units) Table 73. APAC Remimazolam Revenue Forecast by Region (2021-2026) & ($ millions) Table 74. Europe Remimazolam Sales Forecast by Country (2021-2026) & (K Units) Table 75. Europe Remimazolam Revenue Forecast by Country (2021-2026) & ($ millions) Table 76. Middle East & Africa Remimazolam Sales Forecast by Country (2021-2026) & (K Units) Table 77. Middle East & Africa Remimazolam Revenue Forecast by Country (2021-2026) & ($ millions) Table 78. Global Remimazolam Sales Forecast by Type (2021-2026) & (K Units) Table 79. Global Remimazolam Sales Market Share Forecast by Type (2021-2026) Table 80. Global Remimazolam Revenue Forecast by Type (2021-2026) & ($ Millions) Table 81. Global Remimazolam Revenue Market Share Forecast by Type (2021-2026) Table 82. Global Remimazolam Sales Forecast by Application (2021-2026) & (K Units) Table 83. Global Remimazolam Sales Market Share Forecast by Application (2021-2026) Table 84. Global Remimazolam Revenue Forecast by Application (2021-2026) & ($ Millions) Table 85. Global Remimazolam Revenue Market Share Forecast by Application (2021-2026) Table 86. Paion Basic Information, Remimazolam Manufacturing Base, Sales Area and Its Competitors Table 87. Paion Remimazolam Product Offered Table 88. Paion Remimazolam Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E) Table 89. Paion Main Business Table 90. Paion Latest Developments Table 91. Yichang Renfu Pharmaceutical Basic Information, Remimazolam Manufacturing Base, Sales Area and Its Competitors Table 92. Yichang Renfu Pharmaceutical Remimazolam Product Offered Table 93. Yichang Renfu Pharmaceutical Remimazolam Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E) Table 94. Yichang Renfu Pharmaceutical Main Business Table 95. Yichang Renfu Pharmaceutical Latest Developments Table 96. Jiangsu Hengrui Medicine Basic Information, Remimazolam Manufacturing Base, Sales Area and Its Competitors Table 97. Jiangsu Hengrui Medicine Remimazolam Product Offered Table 98. Jiangsu Hengrui Medicine Remimazolam Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E) Table 99. Jiangsu Hengrui Medicine Main Business Table 100. Jiangsu Hengrui Medicine Latest Developments Table 101. Cosmo Pharmaceuticals Basic Information, Remimazolam Manufacturing Base, Sales Area and Its Competitors Table 102. Cosmo Pharmaceuticals Remimazolam Product Offered Table 103. Cosmo Pharmaceuticals Remimazolam Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E) Table 104. Cosmo Pharmaceuticals Main Business Table 105. Cosmo Pharmaceuticals Latest Developments Table 106. Mundipharma Basic Information, Remimazolam Manufacturing Base, Sales Area and Its Competitors Table 107. Mundipharma Remimazolam Product Offered Table 108. Mundipharma Remimazolam Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E) Table 109. Mundipharma Main Business Table 110. Mundipharma Latest Developments Table 111. Pharmascience Basic Information, Remimazolam Manufacturing Base, Sales Area and Its Competitors Table 112. Pharmascience Remimazolam Product Offered Table 113. Pharmascience Remimazolam Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E) Table 114. Pharmascience Main Business Table 115. Pharmascience Latest Developments Table 116. Hana Pharm Basic Information, Remimazolam Manufacturing Base, Sales Area and Its Competitors Table 117. Hana Pharm Remimazolam Product Offered Table 118. Hana Pharm Remimazolam Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E) Table 119. Hana Pharm Main Business Table 120. Hana Pharm Latest Developments List of Figures Figure 1. Picture of Remimazolam Figure 2. Remimazolam Report Years Considered Figure 3. Research Objectives Figure 4. Research Methodology Figure 5. Research Process and Data Source Figure 6. Global Remimazolam Sales Growth Rate 2016-2026 (K Units) Figure 7. Global Remimazolam Revenue Growth Rate 2016-2026 ($ Millions) Figure 8. Remimazolam Sales by Region (2021 & 2026) & ($ millions) Figure 9. Product Picture of 2.5mg Figure 10. Product Picture of 20mg Figure 11. Global Remimazolam Sales Market Share by Type in 2020 Figure 12. Global Remimazolam Revenue Market Share by Type (2016-2021) Figure 13. Remimazolam Consumed in Surgical Anesthesia Figure 14. Global Remimazolam Market: Surgical Anesthesia (2016-2021) & (K Units) Figure 15. Remimazolam Consumed in ICU Sedation Figure 16. Global Remimazolam Market: ICU Sedation (2016-2021) & (K Units) Figure 17. Remimazolam Consumed in Other Figure 18. Global Remimazolam Market: Other (2016-2021) & (K Units) Figure 19. Global Remimazolam Sales Market Share by Application (2016-2021) Figure 20. Global Remimazolam Revenue Market Share by Application in 2020 Figure 21. Remimazolam Revenue Market by Company in 2020 ($ Million) Figure 22. Global Remimazolam Revenue Market Share by Company in 2020 Figure 23. Global Remimazolam Sales Market Share by Regions (2016-2021) Figure 24. Global Remimazolam Revenue Market Share by Region in 2020 Figure 25. Americas Remimazolam Sales 2016-2021 (K Units) Figure 26. Americas Remimazolam Revenue 2016-2021 ($ Millions) Figure 27. APAC Remimazolam Sales 2016-2021 (K Units) Figure 28. APAC Remimazolam Revenue 2016-2021 ($ Millions) Figure 29. Europe Remimazolam Sales 2016-2021 (K Units) Figure 30. Europe Remimazolam Revenue 2016-2021 ($ Millions) Figure 31. Middle East & Africa Remimazolam Sales 2016-2021 (K Units) Figure 32. Middle East & Africa Remimazolam Revenue 2016-2021 ($ Millions) Figure 33. Americas Remimazolam Sales Market Share by Country in 2020 Figure 34. Americas Remimazolam Revenue Market Share by Country in 2020 Figure 35. Americas Remimazolam Sales Market Share by Type in 2020 Figure 36. Americas Remimazolam Sales Market Share by Application in 2020 Figure 37. United States Remimazolam Revenue Growth 2016-2021 ($ Millions) Figure 38. Canada Remimazolam Revenue Growth 2016-2021 ($ Millions) Figure 39. Mexico Remimazolam Revenue Growth 2016-2021 ($ Millions) Figure 40. Brazil Remimazolam Revenue Growth 2016-2021 ($ Millions) Figure 41. APAC Remimazolam Sales Market Share by Region in 2020 Figure 42. APAC Remimazolam Revenue Market Share by Regions in 2020 Figure 43. APAC Remimazolam Sales Market Share by Type in 2020 Figure 44. APAC Remimazolam Sales Market Share by Application in 2020 Figure 45. China Remimazolam Revenue Growth 2016-2021 ($ Millions) Figure 46. Japan Remimazolam Revenue Growth 2016-2021 ($ Millions) Figure 47. Korea Remimazolam Revenue Growth 2016-2021 ($ Millions) Figure 48. Southeast Asia Remimazolam Revenue Growth 2016-2021 ($ Millions) Figure 49. India Remimazolam Revenue Growth 2016-2021 ($ Millions) Figure 50. Australia Remimazolam Revenue Growth 2016-2021 ($ Millions) Figure 51. Europe Remimazolam Sales Market Share by Country in 2020 Figure 52. Europe Remimazolam Revenue Market Share by Country in 2020 Figure 53. Europe Remimazolam Sales Market Share by Type in 2020 Figure 54. Europe Remimazolam Sales Market Share by Application in 2020 Figure 55. Germany Remimazolam Revenue Growth 2016-2021 ($ Millions) Figure 56. France Remimazolam Revenue Growth 2016-2021 ($ Millions) Figure 57. UK Remimazolam Revenue Growth 2016-2021 ($ Millions) Figure 58. Italy Remimazolam Revenue Growth 2016-2021 ($ Millions) Figure 59. Russia Remimazolam Revenue Growth 2016-2021 ($ Millions) Figure 60. Middle East & Africa Remimazolam Sales Market Share by Country in 2020 Figure 61. Middle East & Africa Remimazolam Revenue Market Share by Country in 2020 Figure 62. Middle East & Africa Remimazolam Sales Market Share by Type in 2020 Figure 63. Middle East & Africa Remimazolam Sales Market Share by Application in 2020 Figure 64. Egypt Remimazolam Revenue Growth 2016-2021 ($ Millions) Figure 65. South Africa Remimazolam Revenue Growth 2016-2021 ($ Millions) Figure 66. Israel Remimazolam Revenue Growth 2016-2021 ($ Millions) Figure 67. Turkey Remimazolam Revenue Growth 2016-2021 ($ Millions) Figure 68. GCC Country Remimazolam Revenue Growth 2016-2021 ($ Millions) Figure 69. Channels of Distribution Figure 70. Distributors Profiles |
| ※본 조사보고서 [세계의 레미마졸람 시장예측 2021년-2026년] (코드 : LPI-2201K02162) 판매에 관한 면책사항을 반드시 확인하세요. |
| ※본 조사보고서 [세계의 레미마졸람 시장예측 2021년-2026년] 에 대해서 E메일 문의는 여기를 클릭하세요. |